Methods of using human Zven proteins

Details Methods of using human Zven proteins Methods of using human Zven proteins

2007-02-20

2007-02-20

Kemmerer, Elizabeth (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S008100, C514S012200

Reexamination Certificate

active

10990246

ABSTRACT:
The present invention provides novel uses two members of a new family of human proteins, designated as “Zven,” as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis The Zven1 gene, which resides in human chromosome 3p21.1–3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes.

REFERENCES:
patent: 5891720 (1999-04-01), Moore et al.
patent: 6756479 (2004-06-01), Sheppard et al.
patent: 2002/0115610 (2002-08-01), Zhou et al.
patent: 2002/0187523 (2002-12-01), Tang et al.
patent: 2004/0156842 (2004-08-01), Thompson et al.
patent: 2004/0162238 (2004-08-01), Thompson et al.
patent: 2005/0214800 (2005-09-01), Sheppard et al.
patent: WO99/06550 (1999-02-01), None
patent: WO99/63088 (1999-12-01), None
Li et al. Mol Pharmacol. 2001; 59: 692-698.
Bassil et al. Euro J Pharmacol. 2005; 524: 138-144.
Fedi, et al., “Isolation and Characterizatin of the Human Dkk-1 Homologue, a Novel Inhibitor of Mammalian Wnt Signaling,”J. Biol. Chem. 274(27):19465-19472, Jul. 2, 1999.
Hsieh et al., “A new secreted protein that binds to Wnt proteins and inhibits their activities,”Nature 398:431-436, Apr. 1, 1999.
Jilek et al., “Murine Bv8 gene maps near a synteny breakpoint of mouse chromosome 6 and human 3p21,”Gene 256:189-195, 2000.
Li et al., “Identification of Two Prokineticin cDNAa: Recombinant Proteins Potently Contract Gastrointestinal Smooth Muscle,”Molec. Pharmacol. 59(4):692-698, Apr. 2001.
Weschelberger et al., “The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes,”FEBS Lett. 462:177-181, 1999.
EMBL Database Accession No. AF182069, Oct. 2, 2000.
EMBL Database Accession No. AF333024, May 5, 2001.
EMBL Database Accession No. AF333025, May 5, 2001.
EMBL Database Accession No. AF182066, Dec. 14, 1999.
International Search Report for application No. PCT/US00/31278.
Schweitz et al., “MIT1, a black mamba toxin with a new and highly potent activity on intestinal contraction,”FEBS Lett 461:183-188, 1999.
Boisbouvier et al., “A Structural Homologue of Colipase in Black Mamba Venom Revealed by NMR Floating Disulphide Bridge Analysis,”J. Mol. Biol. 283:205-219, 1998.
Joubert et al., “The Amino Acid Sequence of Protein A fromDendroaspis polylepis polylepis(Black mamba) Venom,”Hoppe-Seyler's Z. Physiol. Chem Bd.361:1787-1794, Dec. 1980.
Morrison et al., “Genetically Engineered Antibdy Molecules.”Advances in Immunology 44:65-92, 1989.
Harlow and Lane, “Antibodies A Laboratory Manual,”Cold Spring Harbor Laboratory, pp. 76, 361, 476, 555 and 626, 1988.

Affiliated with

Also associated with

Rating

Methods of using human Zven proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using human Zven proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using human Zven proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3815177